Global Oncology Precision Medicine Market Growth (Status and Outlook) 2021-2026

  • receipt Report ID : 254557
  • calendar_today Published On: Apr, 2021
  • file_copy Pages: 126
  • list Pharmaceuticals and Healthcare

According to this latest study, the 2021 growth of Oncology Precision Medicine will have significant change from previous year. By the most conservative estimates of global Oncology Precision Medicine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Oncology Precision Medicine market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Oncology Precision Medicine market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.

Applied Sciences

Precision Diagnostics

Digital Health and Information Technology

Precision Therapeutics

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.

Breast Cancer

Lung Cancer

Colorectal Cancer

Prostate Cancer

Cervical Cancer

Other Cancer

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

Abbott Laboratories

Agilent Technologies

Almac

ANGLE plc

Asuragen

BGI Group

Bio-Rad Laboratories

BioMérieux

Bristol Myers Squibb

Roche Holding AG

Gilead Sciences

Illumina

Konica Minolta

LabCorp

MDxHealth

Myriad Genetics

Novartis

OPKO Health

Pacific Biosciences

Quest Diagnostics

Qiagen

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Oncology Precision Medicine Market Size 2016-2026

2.1.2 Oncology Precision Medicine Market Size CAGR by Region 2020 VS 2021 VS 2026

2.2 Oncology Precision Medicine Segment by Type

2.2.1 Applied Sciences

2.2.2 Applied Sciences

2.2.3 Digital Health and Information Technology

2.2.4 Precision Therapeutics

2.3 Oncology Precision Medicine Market Size by Type

2.3.1 Global Oncology Precision Medicine Market Size CAGR by Type

2.3.2 Global Oncology Precision Medicine Market Size Market Share by Type (2016-2021)

2.4 Oncology Precision Medicine Segment by Application

2.4.1 Breast Cancer

2.4.2 Lung Cancer

2.4.3 Colorectal Cancer

2.4.4 Prostate Cancer

2.4.5 Cervical Cancer

2.4.6 Other Cancer

2.5 Oncology Precision Medicine Market Size by Application

2.5.1 Global Oncology Precision Medicine Market Size CAGR by Application

2.5.2 Global Oncology Precision Medicine Market Size Market Share by Application (2016-2021)

3 Oncology Precision Medicine Market Size by Players

3.1 Oncology Precision Medicine Market Size Market Share by Players

3.1.1 Global Oncology Precision Medicine Revenue by Players (2019-2021E)

3.1.2 Global Oncology Precision Medicine Revenue Market Share by Players (2019-2021E)

3.2 Global Oncology Precision Medicine Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Oncology Precision Medicine by Regions

4.1 Oncology Precision Medicine Market Size by Regions (2016-2021)

4.2 Americas Oncology Precision Medicine Market Size Growth (2016-2021)

4.3 APAC Oncology Precision Medicine Market Size Growth (2016-2021)

4.4 Europe Oncology Precision Medicine Market Size Growth (2016-2021)

4.5 Middle East & Africa Oncology Precision Medicine Market Size Growth (2016-2021)

5 Americas

5.1 Americas Oncology Precision Medicine Market Size by Country (2016-2021)

5.2 Americas Oncology Precision Medicine Market Size by Type (2016-2021)

5.3 Americas Oncology Precision Medicine Market Size by Application (2016-2021)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Oncology Precision Medicine Market Size by Region (2016-2021)

6.2 APAC Oncology Precision Medicine Market Size by Type (2016-2021)

6.3 APAC Oncology Precision Medicine Market Size by Application (2016-2021)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Oncology Precision Medicine by Country (2016-2021)

7.2 Europe Oncology Precision Medicine Market Size by Type (2016-2021)

7.3 Europe Oncology Precision Medicine Market Size by Application (2016-2021)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Oncology Precision Medicine by Region (2016-2021)

8.2 Middle East & Africa Oncology Precision Medicine Market Size by Type (2016-2021)

8.3 Middle East & Africa Oncology Precision Medicine Market Size by Application (2016-2021)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Global Oncology Precision Medicine Market Forecast

10.1 Global Oncology Precision Medicine Forecast by Regions (2021-2026)

10.1.1 Global Oncology Precision Medicine Forecast by Regions (2021-2026)

10.1.2 Americas Oncology Precision Medicine Forecast

10.1.3 APAC Oncology Precision Medicine Forecast

10.1.4 Europe Oncology Precision Medicine Forecast

10.1.5 Middle East & Africa Oncology Precision Medicine Forecast

10.2 Americas Oncology Precision Medicine Forecast by Countries (2021-2026)

10.2.1 United States Oncology Precision Medicine Market Forecast

10.2.2 Canada Oncology Precision Medicine Market Forecast

10.2.3 Mexico Oncology Precision Medicine Market Forecast

10.2.4 Brazil Oncology Precision Medicine Market Forecast

10.3 APAC Oncology Precision Medicine Forecast by Region (2021-2026)

10.3.1 China Oncology Precision Medicine Market Forecast

10.3.2 Japan Oncology Precision Medicine Market Forecast

10.3.3 Korea Oncology Precision Medicine Market Forecast

10.3.4 Southeast Asia Oncology Precision Medicine Market Forecast

10.3.5 India Oncology Precision Medicine Market Forecast

10.3.6 Australia Oncology Precision Medicine Market Forecast

10.4 Europe Oncology Precision Medicine Forecast by Country (2021-2026)

10.4.1 Germany Oncology Precision Medicine Market Forecast

10.4.2 France Oncology Precision Medicine Market Forecast

10.4.3 UK Oncology Precision Medicine Market Forecast

10.4.4 Italy Oncology Precision Medicine Market Forecast

10.4.5 Russia Oncology Precision Medicine Market Forecast

10.5 Middle East & Africa Oncology Precision Medicine Forecast by Region (2021-2026)

10.5.1 Egypt Oncology Precision Medicine Market Forecast

10.5.2 South Africa Oncology Precision Medicine Market Forecast

10.5.3 Israel Oncology Precision Medicine Market Forecast

10.5.4 Turkey Oncology Precision Medicine Market Forecast

10.5.5 GCC Countries Oncology Precision Medicine Market Forecast

10.6 Global Oncology Precision Medicine Forecast by Type (2021-2026)

10.7 Global Oncology Precision Medicine Forecast by Application (2021-2026)

11 Key Players Analysis

11.1 Abbott Laboratories

11.1.1 Abbott Laboratories Company Information

11.1.2 Abbott Laboratories Oncology Precision Medicine Product Offered

11.1.3 Abbott Laboratories Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2021)

11.1.4 Abbott Laboratories Main Business Overview

11.1.5 Abbott Laboratories Latest Developments

11.2 Agilent Technologies

11.2.1 Agilent Technologies Company Information

11.2.2 Agilent Technologies Oncology Precision Medicine Product Offered

11.2.3 Agilent Technologies Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2021)

11.2.4 Agilent Technologies Main Business Overview

11.2.5 Agilent Technologies Latest Developments

11.3 Almac

11.3.1 Almac Company Information

11.3.2 Almac Oncology Precision Medicine Product Offered

11.3.3 Almac Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2021)

11.3.4 Almac Main Business Overview

11.3.5 Almac Latest Developments

11.4 ANGLE plc

11.4.1 ANGLE plc Company Information

11.4.2 ANGLE plc Oncology Precision Medicine Product Offered

11.4.3 ANGLE plc Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2021)

11.4.4 ANGLE plc Main Business Overview

11.4.5 ANGLE plc Latest Developments

11.5 Asuragen

11.5.1 Asuragen Company Information

11.5.2 Asuragen Oncology Precision Medicine Product Offered

11.5.3 Asuragen Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2021)

11.5.4 Asuragen Main Business Overview

11.5.5 Asuragen Latest Developments

11.6 BGI Group

11.6.1 BGI Group Company Information

11.6.2 BGI Group Oncology Precision Medicine Product Offered

11.6.3 BGI Group Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2021)

11.6.4 BGI Group Main Business Overview

11.6.5 BGI Group Latest Developments

11.7 Bio-Rad Laboratories

11.7.1 Bio-Rad Laboratories Company Information

11.7.2 Bio-Rad Laboratories Oncology Precision Medicine Product Offered

11.7.3 Bio-Rad Laboratories Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2021)

11.7.4 Bio-Rad Laboratories Main Business Overview

11.7.5 Bio-Rad Laboratories Latest Developments

11.8 BioMérieux

11.8.1 BioMérieux Company Information

11.8.2 BioMérieux Oncology Precision Medicine Product Offered

11.8.3 BioMérieux Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2021)

11.8.4 BioMérieux Main Business Overview

11.8.5 BioMérieux Latest Developments

11.9 Bristol Myers Squibb

11.9.1 Bristol Myers Squibb Company Information

11.9.2 Bristol Myers Squibb Oncology Precision Medicine Product Offered

11.9.3 Bristol Myers Squibb Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2021)

11.9.4 Bristol Myers Squibb Main Business Overview

11.9.5 Bristol Myers Squibb Latest Developments

11.10 Roche Holding AG

11.10.1 Roche Holding AG Company Information

11.10.2 Roche Holding AG Oncology Precision Medicine Product Offered

11.10.3 Roche Holding AG Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2021)

11.10.4 Roche Holding AG Main Business Overview

11.10.5 Roche Holding AG Latest Developments

11. Gilead Sciences

11.11.1 Gilead Sciences Company Information

11.11.2 Gilead Sciences Oncology Precision Medicine Product Offered

11.11.3 Gilead Sciences Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2021)

11.11.4 Gilead Sciences Main Business Overview

11.11.5 Gilead Sciences Latest Developments

11.12 Illumina

11.12.1 Illumina Company Information

11.12.2 Illumina Oncology Precision Medicine Product Offered

11.12.3 Illumina Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2021)

11.12.4 Illumina Main Business Overview

11.12.5 Illumina Latest Developments

11.13 Konica Minolta

11.13.1 Konica Minolta Company Information

11.13.2 Konica Minolta Oncology Precision Medicine Product Offered

11.13.3 Konica Minolta Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2021)

11.13.4 Konica Minolta Main Business Overview

11.13.5 Konica Minolta Latest Developments

11.14 LabCorp

11.14.1 LabCorp Company Information

11.14.2 LabCorp Oncology Precision Medicine Product Offered

11.14.3 LabCorp Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2021)

11.14.4 LabCorp Main Business Overview

11.14.5 LabCorp Latest Developments

11.15 MDxHealth

11.15.1 MDxHealth Company Information

11.15.2 MDxHealth Oncology Precision Medicine Product Offered

11.15.3 MDxHealth Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2021)

11.15.4 MDxHealth Main Business Overview

11.15.5 MDxHealth Latest Developments

11.16 Myriad Genetics

11.16.1 Myriad Genetics Company Information

11.16.2 Myriad Genetics Oncology Precision Medicine Product Offered

11.16.3 Myriad Genetics Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2021)

11.16.4 Myriad Genetics Main Business Overview

11.16.5 Myriad Genetics Latest Developments

11.17 Novartis

11.17.1 Novartis Company Information

11.17.2 Novartis Oncology Precision Medicine Product Offered

11.17.3 Novartis Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2021)

11.17.4 Novartis Main Business Overview

11.17.5 Novartis Latest Developments

11.18 OPKO Health

11.18.1 OPKO Health Company Information

11.18.2 OPKO Health Oncology Precision Medicine Product Offered

11.18.3 OPKO Health Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2021)

11.18.4 OPKO Health Main Business Overview

11.18.5 OPKO Health Latest Developments

11.19 Pacific Biosciences

11.19.1 Pacific Biosciences Company Information

11.19.2 Pacific Biosciences Oncology Precision Medicine Product Offered

11.19.3 Pacific Biosciences Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2021)

11.19.4 Pacific Biosciences Main Business Overview

11.19.5 Pacific Biosciences Latest Developments

11.20 Quest Diagnostics

11.20.1 Quest Diagnostics Company Information

11.20.2 Quest Diagnostics Oncology Precision Medicine Product Offered

11.20.3 Quest Diagnostics Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2021)

11.20.4 Quest Diagnostics Main Business Overview

11.20.5 Quest Diagnostics Latest Developments

11.21 Qiagen

11.21.1 Qiagen Company Information

11.21.2 Qiagen Oncology Precision Medicine Product Offered

11.21.3 Qiagen Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2021)

11.21.4 Qiagen Main Business Overview

11.21.5 Qiagen Latest Developments

12 Research Findings and Conclusion

List of Tables

Table 1. Oncology Precision Medicine Market Size CAGR by Region (2020-2026) & ($ Millions)

Table 2. Major Players of Applied Sciences

Table 3. Major Players of Precision Diagnostics

Table 4. Major Players of Digital Health and Information Technology

Table 5. Major Players of Precision Therapeutics

Table 6. Oncology Precision Medicine Market Size CAGR by Type (2020-2026) & ($ Millions)

Table 7. Global Oncology Precision Medicine Market Size by Type (2016-2021) & ($ Millions)

Table 8. Global Oncology Precision Medicine Market Size Market Share by Type (2016-2021)

Table 9. Oncology Precision Medicine Market Size CAGR by Application (2016-2021) & ($ Millions)

Table 10. Global Oncology Precision Medicine Market Size by Application (2016-2021) & ($ Millions)

Table 11. Global Oncology Precision Medicine Market Size Market Share by Application (2016-2021)

Table 12. Global Oncology Precision Medicine Revenue by Players (2019-2021E) & ($ Millions)

Table 13. Global Oncology Precision Medicine Revenue Market Share by Players (2019-2021E)

Table 14. Oncology Precision Medicine Key Players Head office and Products Offered

Table 15. Oncology Precision Medicine Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)

Table 16. New Products and Potential Entrants

Table 17. Mergers & Acquisitions, Expansion

Table 18. Global Oncology Precision Medicine Market Size by Regions 2016-2021 & ($ Millions)

Table 19. Global Oncology Precision Medicine Market Size Market Share by Regions 2016-2021

Table 20. Americas Oncology Precision Medicine Market Size by Country (2016-2021) & ($ Millions)

Table 21. Americas Oncology Precision Medicine Market Size Market Share by Country (2016-2021)

Table 22. Americas Oncology Precision Medicine Market Size by Type (2016-2021) & ($ Millions)

Table 23. Americas Oncology Precision Medicine Market Size Market Share by Type (2016-2021)

Table 24. Americas Oncology Precision Medicine Market Size by Application (2016-2021) & ($ Millions)

Table 25. Americas Oncology Precision Medicine Market Size Market Share by Application (2016-2021)

Table 26. APAC Oncology Precision Medicine Market Size by Region (2016-2021) & ($ Millions)

Table 27. APAC Oncology Precision Medicine Market Size Market Share by Region (2016-2021)

Table 28. APAC Oncology Precision Medicine Market Size by Type (2016-2021) & ($ Millions)

Table 29. APAC Oncology Precision Medicine Market Size Market Share by Type (2016-2021)

Table 30. APAC Oncology Precision Medicine Market Size by Application (2016-2021) & ($ Millions)

Table 31. APAC Oncology Precision Medicine Market Size Market Share by Application (2016-2021)

Table 32. Europe Oncology Precision Medicine Market Size by Country (2016-2021) & ($ Millions)

Table 33. Europe Oncology Precision Medicine Market Size Market Share by Country (2016-2021)

Table 34. Europe Oncology Precision Medicine Market Size by Type (2016-2021) & ($ Millions)

Table 35. Europe Oncology Precision Medicine Market Size Market Share by Type (2016-2021)

Table 36. Europe Oncology Precision Medicine Market Size by Application (2016-2021) & ($ Millions)

Table 37. Europe Oncology Precision Medicine Market Size Market Share by Application (2016-2021)

Table 38. Middle East & Africa Oncology Precision Medicine Market Size by Region (2016-2021) & ($ Millions)

Table 39. Middle East & Africa Oncology Precision Medicine Market Size Market Share by Region (2016-2021)

Table 40. Middle East & Africa Oncology Precision Medicine Market Size by Type (2016-2021) & ($ Millions)

Table 41. Middle East & Africa Oncology Precision Medicine Market Size Market Share by Type (2016-2021)

Table 42. Middle East & Africa Oncology Precision Medicine Market Size by Application (2016-2021) & ($ Millions)

Table 43. Middle East & Africa Oncology Precision Medicine Market Size Market Share by Application (2016-2021)

Table 44. Key and Potential Regions of Oncology Precision Medicine

Table 45. Key Application and Potential Industries of Oncology Precision Medicine

Table 46. Key Challenges of Oncology Precision Medicine

Table 47. Key Trends of Oncology Precision Medicine

Table 48. Global Oncology Precision Medicine Market Size Forecast by Regions (2021-2026) & ($ Millions)

Table 49. Global Oncology Precision Medicine Market Size Market Share Forecast by Regions (2021-2026)

Table 50. Global Oncology Precision Medicine Market Size Forecast by Type (2021-2026) & ($ Millions)

Table 51. Global Oncology Precision Medicine Market Size Market Share Forecast by Type (2021-2026)

Table 52. Global Oncology Precision Medicine Market Size Forecast by Application (2021-2026) & ($ Millions)

Table 53. Global Oncology Precision Medicine Market Size Market Share Forecast by Application (2021-2026)

Table 54. Abbott Laboratories Details, Company Type, Oncology Precision Medicine Area Served and Its Competitors

Table 55. Abbott Laboratories Oncology Precision Medicine Product Offered

Table 56. Abbott Laboratories Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 57. Abbott Laboratories Main Business

Table 58. Abbott Laboratories Latest Developments

Table 59. Agilent Technologies Details, Company Type, Oncology Precision Medicine Area Served and Its Competitors

Table 60. Agilent Technologies Oncology Precision Medicine Product Offered

Table 61. Agilent Technologies Main Business

Table 62. Agilent Technologies Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 63. Agilent Technologies Latest Developments

Table 64. Almac Details, Company Type, Oncology Precision Medicine Area Served and Its Competitors

Table 65. Almac Oncology Precision Medicine Product Offered

Table 66. Almac Main Business

Table 67. Almac Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 68. Almac Latest Developments

Table 69. ANGLE plc Details, Company Type, Oncology Precision Medicine Area Served and Its Competitors

Table 70. ANGLE plc Oncology Precision Medicine Product Offered

Table 71. ANGLE plc Main Business

Table 72. ANGLE plc Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 73. ANGLE plc Latest Developments

Table 74. Asuragen Details, Company Type, Oncology Precision Medicine Area Served and Its Competitors

Table 75. Asuragen Oncology Precision Medicine Product Offered

Table 76. Asuragen Main Business

Table 77. Asuragen Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 78. Asuragen Latest Developments

Table 79. BGI Group Details, Company Type, Oncology Precision Medicine Area Served and Its Competitors

Table 80. BGI Group Oncology Precision Medicine Product Offered

Table 81. BGI Group Main Business

Table 82. BGI Group Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 83. BGI Group Latest Developments

Table 84. Bio-Rad Laboratories Details, Company Type, Oncology Precision Medicine Area Served and Its Competitors

Table 85. Bio-Rad Laboratories Oncology Precision Medicine Product Offered

Table 86. Bio-Rad Laboratories Main Business

Table 87. Bio-Rad Laboratories Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 88. Bio-Rad Laboratories Latest Developments

Table 89. BioMérieux Details, Company Type, Oncology Precision Medicine Area Served and Its Competitors

Table 90. BioMérieux Oncology Precision Medicine Product Offered

Table 91. BioMérieux Main Business

Table 92. BioMérieux Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 93. BioMérieux Latest Developments

Table 94. Bristol Myers Squibb Details, Company Type, Oncology Precision Medicine Area Served and Its Competitors

Table 95. Bristol Myers Squibb Oncology Precision Medicine Product Offered

Table 96. Bristol Myers Squibb Main Business

Table 97. Bristol Myers Squibb Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 98. Bristol Myers Squibb Latest Developments

Table 99. Roche Holding AG Details, Company Type, Oncology Precision Medicine Area Served and Its Competitors

Table 100. Roche Holding AG Oncology Precision Medicine Product Offered

Table 101. Roche Holding AG Main Business

Table 102. Roche Holding AG Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 103. Roche Holding AG Latest Developments

Table 104. Gilead Sciences Details, Company Type, Oncology Precision Medicine Area Served and Its Competitors

Table 105. Gilead Sciences Oncology Precision Medicine Product Offered

Table 106. Gilead Sciences Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 107. Gilead Sciences Main Business

Table 108. Gilead Sciences Latest Developments

Table 109. Illumina Details, Company Type, Oncology Precision Medicine Area Served and Its Competitors

Table 110. Illumina Oncology Precision Medicine Product Offered

Table 111. Illumina Main Business

Table 112. Illumina Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 113. Illumina Latest Developments

Table 114. Konica Minolta Details, Company Type, Oncology Precision Medicine Area Served and Its Competitors

Table 115. Konica Minolta Oncology Precision Medicine Product Offered

Table 116. Konica Minolta Main Business

Table 117. Konica Minolta Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 118. Konica Minolta Latest Developments

Table 119. LabCorp Details, Company Type, Oncology Precision Medicine Area Served and Its Competitors

Table 120. LabCorp Oncology Precision Medicine Product Offered

Table 121. LabCorp Main Business

Table 122. LabCorp Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 123. LabCorp Latest Developments

Table 124. MDxHealth Details, Company Type, Oncology Precision Medicine Area Served and Its Competitors

Table 125. MDxHealth Oncology Precision Medicine Product Offered

Table 126. MDxHealth Main Business

Table 127. MDxHealth Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 128. MDxHealth Latest Developments

Table 129. Myriad Genetics Details, Company Type, Oncology Precision Medicine Area Served and Its Competitors

Table 130. Myriad Genetics Oncology Precision Medicine Product Offered

Table 131. Myriad Genetics Main Business

Table 132. Myriad Genetics Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 133. Myriad Genetics Latest Developments

Table 134. Novartis Details, Company Type, Oncology Precision Medicine Area Served and Its Competitors

Table 135. Novartis Oncology Precision Medicine Product Offered

Table 136. Novartis Main Business

Table 137. Novartis Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 138. Novartis Latest Developments

Table 139. OPKO Health Details, Company Type, Oncology Precision Medicine Area Served and Its Competitors

Table 140. OPKO Health Oncology Precision Medicine Product Offered

Table 141. OPKO Health Main Business

Table 142. OPKO Health Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 143. OPKO Health Latest Developments

Table 144. Pacific Biosciences Details, Company Type, Oncology Precision Medicine Area Served and Its Competitors

Table 145. Pacific Biosciences Oncology Precision Medicine Product Offered

Table 146. Pacific Biosciences Main Business

Table 147. Pacific Biosciences Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 148. Pacific Biosciences Latest Developments

Table 149. Quest Diagnostics Details, Company Type, Oncology Precision Medicine Area Served and Its Competitors

Table 150. Quest Diagnostics Oncology Precision Medicine Product Offered

Table 151. Quest Diagnostics Main Business

Table 152. Quest Diagnostics Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 153. Quest Diagnostics Latest Developments

Table 154. Qiagen Details, Company Type, Oncology Precision Medicine Area Served and Its Competitors

Table 155. Qiagen Oncology Precision Medicine Product Offered

Table 156. Qiagen Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 157. Qiagen Main Business

Table 158. Qiagen Latest Developments

List of Figures

Figure 1. Oncology Precision Medicine Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Oncology Precision Medicine Market Size Growth Rate 2016-2026 ($ Millions)

Figure 6. Global Oncology Precision Medicine Market Size Market Share by Type in 2020

Figure 7. Oncology Precision Medicine in Breast Cancer

Figure 8. Global Oncology Precision Medicine Market: Breast Cancer (2016-2021) & ($ Millions)

Figure 9. Oncology Precision Medicine in Lung Cancer

Figure 10. Global Oncology Precision Medicine Market: Lung Cancer (2016-2021) & ($ Millions)

Figure 11. Oncology Precision Medicine in Colorectal Cancer

Figure 12. Global Oncology Precision Medicine Market: Colorectal Cancer (2016-2021) & ($ Millions)

Figure 13. Oncology Precision Medicine in Prostate Cancer

Figure 14. Global Oncology Precision Medicine Market: Prostate Cancer (2016-2021) & ($ Millions)

Figure 15. Oncology Precision Medicine in Cervical Cancer

Figure 16. Global Oncology Precision Medicine Market: Cervical Cancer (2016-2021) & ($ Millions)

Figure 17. Oncology Precision Medicine in Other Cancer

Figure 18. Global Oncology Precision Medicine Market: Other Cancer (2016-2021) & ($ Millions)

Figure 19. Global Oncology Precision Medicine Market Size Market Share by Application in 2020

Figure 20. Global Oncology Precision Medicine Revenue Market Share by Player in 2020

Figure 21. Global Oncology Precision Medicine Market Size Market Share by Regions (2016-2021)

Figure 22. Americas Oncology Precision Medicine Market Size 2016-2021 ($ Millions)

Figure 23. APAC Oncology Precision Medicine Market Size 2016-2021 ($ Millions)

Figure 24. Europe Oncology Precision Medicine Market Size 2016-2021 ($ Millions)

Figure 25. Middle East & Africa Oncology Precision Medicine Market Size 2016-2021 ($ Millions)

Figure 26. Americas Oncology Precision Medicine Market Size Market Share by Country in 2020

Figure 27. Americas Oncology Precision Medicine Market Size Market Share by Type in 2020

Figure 28. Americas Oncology Precision Medicine Market Size Market Share by Application in 2020

Figure 29. United States Oncology Precision Medicine Market Size Growth 2016-2021 ($ Millions)

Figure 30. Canada Oncology Precision Medicine Market Size Growth 2016-2021 ($ Millions)

Figure 31. Mexico Oncology Precision Medicine Market Size Growth 2016-2021 ($ Millions)

Figure 32. APAC Oncology Precision Medicine Market Size Market Share by Regions in 2020

Figure 33. APAC Oncology Precision Medicine Market Size Market Share by Type in 2020

Figure 34. APAC Oncology Precision Medicine Market Size Market Share by Application in 2020

Figure 35. China Oncology Precision Medicine Market Size Growth 2016-2021 ($ Millions)

Figure 36. Japan Oncology Precision Medicine Market Size Growth 2016-2021 ($ Millions)

Figure 37. Korea Oncology Precision Medicine Market Size Growth 2016-2021 ($ Millions)

Figure 38. Southeast Asia Oncology Precision Medicine Market Size Growth 2016-2021 ($ Millions)

Figure 39. India Oncology Precision Medicine Market Size Growth 2016-2021 ($ Millions)

Figure 40. Australia Oncology Precision Medicine Market Size Growth 2016-2021 ($ Millions)

Figure 41. Europe Oncology Precision Medicine Market Size Market Share by Country in 2020

Figure 42. Europe Oncology Precision Medicine Market Size Market Share by Type in 2020

Figure 43. Europe Oncology Precision Medicine Market Size Market Share by Application in 2020

Figure 44. Germany Oncology Precision Medicine Market Size Growth 2016-2021 ($ Millions)

Figure 45. France Oncology Precision Medicine Market Size Growth 2016-2021 ($ Millions)

Figure 46. UK Oncology Precision Medicine Market Size Growth 2016-2021 ($ Millions)

Figure 47. Italy Oncology Precision Medicine Market Size Growth 2016-2021 ($ Millions)

Figure 48. Russia Oncology Precision Medicine Market Size Growth 2016-2021 ($ Millions)

Figure 49. Middle East & Africa Oncology Precision Medicine Market Size Market Share by Region in 2020

Figure 50. Middle East & Africa Oncology Precision Medicine Market Size Market Share by Type in 2020

Figure 51. Middle East & Africa Oncology Precision Medicine Market Size Market Share by Application in 2020

Figure 52. Egypt Oncology Precision Medicine Market Size Growth 2016-2021 ($ Millions)

Figure 53. South Africa Oncology Precision Medicine Market Size Growth 2016-2021 ($ Millions)

Figure 54. Israel Oncology Precision Medicine Market Size Growth 2016-2021 ($ Millions)

Figure 55. Turkey Oncology Precision Medicine Market Size Growth 2016-2021 ($ Millions)

Figure 56. GCC Country Oncology Precision Medicine Market Size Growth 2016-2021 ($ Millions)

Figure 57. Americas Oncology Precision Medicine Market Size 2021-2026 ($ Millions)

Figure 58. APAC Oncology Precision Medicine Market Size 2021-2026 ($ Millions)

Figure 59. Europe Oncology Precision Medicine Market Size 2021-2026 ($ Millions)

Figure 60. Middle East & Africa Oncology Precision Medicine Market Size 2021-2026 ($ Millions)

Figure 61. United States Oncology Precision Medicine Market Size 2021-2026 ($ Millions)

Figure 62. Canada Oncology Precision Medicine Market Size 2021-2026 ($ Millions)

Figure 63. Mexico Oncology Precision Medicine Market Size 2021-2026 ($ Millions)

Figure 64. Brazil Oncology Precision Medicine Market Size 2021-2026 ($ Millions)

Figure 65. China Oncology Precision Medicine Market Size 2021-2026 ($ Millions)

Figure 66. Japan Oncology Precision Medicine Market Size 2021-2026 ($ Millions)

Figure 67. Korea Oncology Precision Medicine Market Size 2021-2026 ($ Millions)

Figure 68. Southeast Asia Oncology Precision Medicine Market Size 2021-2026 ($ Millions)

Figure 69. India Oncology Precision Medicine Market Size 2021-2026 ($ Millions)

Figure 70. Australia Oncology Precision Medicine Market Size 2021-2026 ($ Millions)

Figure 71. Germany Oncology Precision Medicine Market Size 2021-2026 ($ Millions)

Figure 72. France Oncology Precision Medicine Market Size 2021-2026 ($ Millions)

Figure 73. UK Oncology Precision Medicine Market Size 2021-2026 ($ Millions)

Figure 74. Italy Oncology Precision Medicine Market Size 2021-2026 ($ Millions)

Figure 75. Russia Oncology Precision Medicine Market Size 2021-2026 ($ Millions)

Figure 76. Spain Oncology Precision Medicine Market Size 2021-2026 ($ Millions)

Figure 77. Egypt Oncology Precision Medicine Market Size 2021-2026 ($ Millions)

Figure 78. South Africa Oncology Precision Medicine Market Size 2021-2026 ($ Millions)

Figure 79. Israel Oncology Precision Medicine Market Size 2021-2026 ($ Millions)

Figure 80. Turkey Oncology Precision Medicine Market Size 2021-2026 ($ Millions)

Figure 81. GCC Country Oncology Precision Medicine Market Size 2021-2026 ($ Millions)

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery